Clinical Trial Update: Apabetalone for Pulmonary Arterial Hypertension [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for apabetalone in pulmonary arterial hypertension is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• apabetalone (apabetalone)

Snippet

Sponsor: Laval University | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: UNKNOWN